Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

3

Evaluation of Oral Thymomodulin Effect on the Patients with Chronic Viral Hepatitis B

Chul Hun Chung , Soong Hwan Lee , Yong Hyeon Jo , Yeon Soo kim , Seung Woo Nam , Oh Young Lee , Dong Soo Ha , Joo Hyun Sohn , Dong Hoo Lee

Clin Mol Hepatol. 1996;2(1):47-53.

View: 3276 Download: 40

Comparison of the Incidence of Hepatocellular Carcinoma in HBV - and HCV - associated Liver Cirrhosis ; A Prospective Study

Hyo Suk lee , Jun Haeng Lee , Moon Suk Choi , Chung Yong kim

Clin Mol Hepatol. 1996;2(1):21-28.

View: 2360 Download: 14

Original Article

Phase 1 trial of the safety, pharmacokinetics, and antiviral activity of EDP-514 in untreated viremic chronic hepatitis B patients

Man-Fung Yuen, Wan-Long Chuang, Cheng-Yuan Peng, Wen-Juei Jeng, Wei-Wen Su, Ting-Tsung Chang, Chi-Yi Chen, Yao-Chun Hsu, Guy De La Rosa, Alaa Ahmad, Ed Luo, Annie L. Conery

Received December 16, 2023 Accepted March 25, 2024

DOI: https://doi.org/10.3350/cmh.2023.0535 [Epub ahead of print]

View: 760 Download: 61

Reply to Correspondence

Reply to “Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B”

Pin-Nan Cheng, Ming-Lung Yu

Received April 5, 2024 Accepted April 9, 2024

DOI: https://doi.org/10.3350/cmh.2024.0228 [Epub ahead of print]

View: 496 Download: 21

Original Article

Extrahepatic Malignancies and Antiviral Drugs for Chronic Hepatitis B: A Nationwide Cohort Study

Moon Haeng Hur, Dong Hyeon Lee, Jeong-Hoon Lee, Mi-Sook Kim, Jeayeon Park, Hyunjae Shin, Sung Won Chung, Hee Jin Cho, Min Kyung Park, Heejoon Jang, Yun Bin Lee, Su Jong Yu, Sang Hyub Lee, Yong Jin Jung, Yoon Jun Kim, Jung-Hwan Yoon

Received January 20, 2024 Accepted May 9, 2024

DOI: https://doi.org/10.3350/cmh.2024.0055 [Accepted]

View: 417 Download: 59

Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction

Mehrangiz Dezhbord, Seong Ho Kim, Soree Park, Da Rae Lee, Nayeon Kim, Juhee Won, Ah Ram Lee, Dong-Sik Kim, Kyun-Hwan Kim

Received January 22, 2024 Accepted May 13, 2024

DOI: https://doi.org/10.3350/cmh.2024.0060 [Accepted]

View: 835 Download: 111

Editorial

MAFLD Is A Ubiquitous Latent Cofactor in Viral- and Alcoholic-related Hepatocellular Carcinoma

Toru Nakamura, Masahito Nakano, Tsubasa Tsutsumi, Keisuke Amano, Takumi Kawaguchi

Received May 18, 2024 Accepted May 20, 2024

DOI: https://doi.org/10.3350/cmh.2024.0372 [Accepted]

View: 394 Download: 25

Original Article

Genetically redirected HBV-specific T cells target HBsAg-positive hepatocytes and primary lesions in HBV-associated HCC

Xueshuai Wan, Karin Wisskirchen, Tao Jin, Lu Yang, Xiaorui Wang, Xiang’an Wu, Fang Liu, Yu Wu, Christy Ma, Yong Pang, Qi Li, Ke Zhang, Ulrike Protzer, Shunda Du

Received January 20, 2024 Accepted May 28, 2024

DOI: https://doi.org/10.3350/cmh.2024.0058 [Accepted]

View: 414 Download: 52

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 |

Viewed By 6733	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5782	MAFLD: How is it different from NAFLD?
Viewed By 5535	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4846	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4472	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Cited By 169	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 108	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 108	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 80	MAFLD: How is it different from NAFLD?
Cited By 77	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search